RHJA
SMED

Rice Hall James & Associates’s Sharps Compliance Corp SMED Stock Holding History

Rice Hall James & Associates’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-43,068
Closed -$237K – 315
2016
Q1 		$237K Sell
43,068
-665
-2% -$4.03K 0.01% 285
2015
Q4 		$380K Buy
43,733
+1,156
+3% +$10K 0.02% 267
2015
Q3 		$373K Sell
42,577
-1,903
-4% -$13.8K 0.02% 274
2015
Q2 		$309K Sell
44,480
-4,659
-9% -$29.2K 0.02% 286
2015
Q1 		$312K Buy
49,139
+1,279
+3% +$6.46K 0.02% 295
2014
Q4 		$204K Buy
47,860
+684
+1% +$3.04K 0.01% 298
2014
Q3 		$206K Buy
47,176
+586
+1% +$2.64K 0.01% 289
2014
Q2 		$205K Buy
46,590
+678
+1% +$2.8K 0.01% 294
2014
Q1 		$210K Buy
45,912
+1,811
+4% +$8.54K 0.02% 294
2013
Q4 		$209K Buy
44,101
+26,320
+148% +$112K 0.02% 291
2013
Q3 		$55K Hold
17,781
– – 0.01% 272
2013
Q2 		$47K Buy
+17,781
New +$51.7K ﹤0.01% 270

Other funds holding SMED

GF
Goodman Financial Houston, Texas $647M AUM 24.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
AHC
Anderson Hoagland & Co St Louis, Missouri $1.28B AUM 29.05% 1-Year Est. Return

Rice Hall James & Associates's SMED Position: Q2 2016 in Review

Rice Hall James & Associates sold out of Sharps Compliance Corp (SMED) in Q2 2016, closing a stake of 43,068 shares — an estimated $237K sold.

Rice Hall James & Associates first reported a position in SMED in Q2 2013 and held it in 12 quarters. The position peaked at $380K in Q4 2015. 38 funds tracked by Wall St. Rank hold SMED as of Q2 2016.

  • Rice Hall James & Associates reported no remaining Sharps Compliance Corp position as of Q2 2016 after selling out during the quarter.
  • Rice Hall James & Associates sold 43,068 Sharps Compliance Corp shares in Q2 2016, an estimated $237K.
  • Rice Hall James & Associates first reported a position in Sharps Compliance Corp in Q2 2013 and held it in 12 quarters.
  • Rice Hall James & Associates's Sharps Compliance Corp position peaked at $380K in Q4 2015.
  • 38 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q2 2016.

Based on Rice Hall James & Associates's 13F filing for Q2 2016, filed 27 Jul 2016.